Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia

References

• Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552.
   PubMed Web of Science ®Google Scholar
• Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349(7):640–649.
   PubMed Web of Science ®Google Scholar
• Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515–5523.
   PubMed Web of Science ®Google Scholar
• Elitzur S, Houri-Shtrecher R, Yackobovitz-Gavan M, et al. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia. J Pediatr Endocrinol Metab. 2017;30(8):869–877.
   PubMed Web of Science ®Google Scholar
• Mills JL, Fears TR, Robison LL, et al. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr. 1997;131(4):598–602.
   PubMed Web of Science ®Google Scholar
• Wallace WHB, Shalet SM, Tetlow LJ, et al. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol. 1993;21(5):333–339.
   PubMedGoogle Scholar
• Byrne J, Fears TR, Mills JL, et al. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(7):589–597.
   PubMed Web of Science ®Google Scholar
• Brougham MFH, Wallace WHB. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol. 2005;131(2):143–155.
   PubMed Web of Science ®Google Scholar
• Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98(13):890–896.
   PubMed Web of Science ®Google Scholar
• Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91(5):1723–1728.
   PubMed Web of Science ®Google Scholar
• Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(16):2677–2685.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Stratton KL, Leisenring WM, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016;17(5):567–576.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Brewster DH, Wood R, et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod. 2018;33(7):1281–1290.
   PubMed Web of Science ®Google Scholar
• van Rooij IAJ. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17(12):3065–3071.
   PubMed Web of Science ®Google Scholar
• Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95(1):170–175.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Wallace WHB. Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril. 2013;99(6):1469–1475.
   PubMed Web of Science ®Google Scholar
• Di Paola R, Costantini C, Tecchio C, et al. Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies. Oncologist. 2013;18(12):1307–1314.
   PubMed Web of Science ®Google Scholar
• Green DM, Nolan VG, Goodman PJ, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61(1):53–67.
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Mansournia MA, Solaymani-Dodaran M, et al. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric. 2014;17(5):591–597.
   PubMed Web of Science ®Google Scholar
• Van Dorp W, Mulder RL, Kremer LCM, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the international late effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium. J Clin Oncol. 2016;34(28):3440–3450.
   PubMed Web of Science ®Google Scholar
• Van Dorp W, Haupt R, Anderson RA, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018;36(21):2169–2180.
   PubMed Web of Science ®Google Scholar
• Overbeek A, van den Berg MH, van Leeuwen FE, et al. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treat Rev. 2017;53(2017):10–24.
   PubMedGoogle Scholar
• Krawczuk-Rybak M, Płonowski M, Leszczyńska E, et al. The influence of different intensity of treatment on hormonal markers of gonadal function in acute lymphoblastic leukemia survivors. Hematol Oncol. 2019;37(5):609–616.
   PubMed Web of Science ®Google Scholar
• Shandley LM, Fothergill A, Spencer JB, et al. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018;109(3):516–525.e1.
   PubMed Web of Science ®Google Scholar
• Deb S, Campbell BK, Pincott-Allen C, et al. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol. 2012;39(5):574–580.
   PubMed Web of Science ®Google Scholar
• Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30(10):2364–2375.
   PubMed Web of Science ®Google Scholar
• Thomas-Teinturier C, Allodji RS, Svetlova E, et al. Ovarian reserve after treatment with alkylating agents during childhood. Hum Reprod. 2015;30(6):1437–1446.
   PubMed Web of Science ®Google Scholar
• Van Den Berg MH, Overbeek A, Lambalk CB, DCOG LATER-VEVO Study Group, et al. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum Reprod. 2018;33(8):1474–1488.
   PubMed Web of Science ®Google Scholar